DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Wedbush Maintains Outperform on Aquestive Therapeutics, Raises Price Target to $36

Wedbush analyst Liana Moussatos maintains Aquestive Therapeutics (NASDAQ:AQST) with a Outperform and raises the price target from $35 to $36.

Benzinga · 02/10/2020 18:28

Wedbush analyst Liana Moussatos maintains Aquestive Therapeutics (NASDAQ:AQST) with a Outperform and raises the price target from $35 to $36.